•
Sep 30, 2016

Jazz Pharmaceuticals Q3 2016 Earnings Report

Total Revenue
$374M
Previous year: $341M
+9.8%
EPS
$2.57
Previous year: $2.52
+2.0%
Gross Profit
$350M
Previous year: $312M
+12.0%
Cash and Equivalents
$367M
Previous year: $999M
-63.3%
Total Assets
$4.93B
Previous year: $3.46B
+42.3%

Jazz Pharmaceuticals

Jazz Pharmaceuticals